Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen. Read more here.

PM Narendra Modi slammed the Congress party for disrespecting President Droupadi Murmu, saying they've insulted not just her, ...

In the previous Budget, finance minister Nirmala Sitharaman announced an impressive allocation of INR 1,000 crore, giving the ...

The union government will invest Rs34,300 crore over the next seven years, to build a resilient value chain for critical ...

On US President Trump's statement warning BRICS nations, Congress MP Shashi Tharoor says, "I heard this comment by President ...

Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...

Jefferies analyst Peter Welford maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

PM Modi's remarks on foreign interference during Budget 2025 highlight India's focus on sovereignty and development, stirring political discussions.- Watch Video on English Oneindia ...

Looking ahead to 2025, Novartis maintains an optimistic stance, forecasting mid to high single-digit sales growth and anticipating even stronger operational core earnings in the high single to low ...

The Indian government woke up to reality of its digital status, after a Chinese startup launched a low-cost foundational AI ...

If we're being frank, which is how we roll in the Rocket Report, some of Orbex's recent activity does not inspire confidence.

Swiss pharmaceutical giant Novartis on Friday reported fourth-quarter results after repeatedly raising its full-year guidance ...